Results for
""HIV Protease Inhibitors""[mesh_terms]

Lopinavir-Ritonavir: a new protease inhibitor.

E M Mangum, K K Graham

Pharmacotherapy 2002;21(11):1352-63

New anti-HIV protease inhibitors provide more treatment options.

Jeffrey Nadler

AIDS patient care and STDs 2004;17(11):551-64

Impact of nevirapine on lipid metabolism.

Bonaventura Clotet, Marc van der Valk, Eugenia Negredo, Peter Reiss

Journal of acquired immune deficiency syndromes (1999) 2003;34 Suppl 1():S79-84

Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants.

Shin-Ichiro Hattori, Hironori Hayashi, Haydar Bulut, Kalapala Venkateswara Rao, Prasanth R Nyalapatla, Kazuya Hasegawa, Manabu Aoki, Arun K Ghosh, Hiroaki Mitsuya

Antimicrobial agents and chemotherapy 2020;63(6):e02635-18

HIV and hyperlipidemia: current recommendations and treatment.

Joyce K Anastasi, Bernadette Capili

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 2006;15(1):14-9, 35; quiz 20

Complexity in modeling and understanding protonation states: computational titration of HIV-1-protease-inhibitor complexes.

Ashutosh Tripathi, Micaela Fornabaio, Francesca Spyrakis, Andrea Mozzarelli, Pietro Cozzini, Glen E Kellogg

Chemistry & biodiversity 2008;4(11):2564-77

Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.

Pablo Barreiro, Teresa García-Benayas, Vincent Soriano, Joel Gallant

AIDS reviews 2003;4(4):233-41

Renal toxicity of protease inhibitors.

A J Olyaei, A M deMattos, W M Bennett

Current opinion in nephrology and hypertension 2001;9(5):473-6

Hyperlipidemia and inhibitors of HIV protease.

O Distler, D A Cooper, R J Deckelbaum, S L Sturley

Current opinion in clinical nutrition and metabolic care 2001;4(2):99-103

Virtual Screening for HIV Protease Inhibitors Using a Novel Database Filtering Procedure.

Kalev Takkis, Alfonso T García-Sosa, Sulev Sild

Molecular informatics 2018;34(6-7):485-92

Effects of plant extracts on HIV-1 protease.

Jaime Ribeiro Filho, Heloina de Sousa Falcão, Leônia Maria Batista, José Maria Barbosa Filho, Márcia Regina Piuvezam

Current HIV research 2011;8(7):531-44

Indinavir crystallization around the loop of Henle: experimental evidence.

J P Dieleman, S Salahuddin, Y S Hsu, D M Burger, I C Gyssens, M C Sturkenboom, B H Stricker, D J Kok

Journal of acquired immune deficiency syndromes (1999) 2003;28(1):9-13

Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.

The Journal of the Association of Nurses in AIDS Care : JANAC 2002;13(2):86-7

Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.

H L Kirschenbaum, H B Fung, R Hameed

Clinical therapeutics 2000;22(5):549-72

Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages.

Carlo Federico Perno, Valentina Svicher, Stefano Aquaro, Ana Borrajo, Alessandro Ranazzi, Michela Pollicita, Rosalinda Bruno, Andrea Modesti, Claudia Alteri

Viruses 2018;9(10):277